TY - JOUR
T1 - Cardiometabolic Risk Among Internal Medicine Specialists in Indonesia (CARMEINA)
AU - Ginanjar, Eka
AU - Salim, Simon
AU - Nasution, Sally Aman
AU - Sukrisman, Lugyanti
AU - Yunihastuti, Evy
AU - Rachman, Andhika
AU - Pitoyo, Ceva Wicaksono
AU - Nufus, Hayatun
AU - Muhadi, Muhadi
AU - Susanto, Hermawan
AU - Bintoro, Siprianus Ugroseno Yudho
AU - Darmadi, Darmadi
AU - Tambunan, Asri Ludin
AU - Purnomo, Hery Djagat
AU - Aman, Andi Makbul
AU - Hartopo, Anggoro Budi
AU - Ikhsan, Mohammad Robikhul
AU - Selfie, Selfie
AU - Mekah, Ahmad
AU - Ritonga, Ervita
AU - Wijaya, Indra
AU - Mahadita, Gede Wira
AU - Gotera, Wira
AU - Partan, Radiyati Umi
AU - Ahmad, Zen
AU - Abubakar, Azzaki
AU - Diah, Muhammad
AU - Samsu, Nur
AU - Putranto, Wachid
AU - Sumandjar, Tatar
AU - Alexander, Reinaldo
AU - Prihatini, Johana
AU - Rosdiana, Dani
AU - Wakimin, Juwanto
AU - Hendratta, Cecilia
AU - Rotty, Linda Wilhelma Ancella
AU - Hanif, Akmal Mufriady
AU - Harun, Harnavi
AU - Indrasari, Astried
AU - Yakti, Kuntjoro
AU - Winulyo, Erwanto Budi
AU - Erwin, Erwin
AU - Pura, Lukman
AU - Djallalluddin, Djallalluddin
AU - Abimanyu, Abimanyu
AU - Satriya, Giri
AU - Kusuma, Sutiadi
AU - Panjaitan, Andi M.H.
AU - Hakim, Suharno
AU - Elfiani, Elfiani
AU - Gunawan, Budiman
AU - Nachrowi, Annisa Puspitasari
AU - Nursetiyanto, Kongko H.
AU - Girsang, Kurniakin W.S.
AU - Koswandi, Arif
AU - Pangkahila, Erwin A.
AU - Lewai, Andreas N.F.
AU - Anggoro, Joko
AU - Nurbayati, Dayang
AU - Darkuthni, Fahmi R.
AU - Sanusi, Arfan
AU - Irianto, Petrus
AU - Komariatun, Komariatun
AU - Kurniati, Annelin
AU - Aswar, Haeril
AU - Mokoginta, Nelyan H.
AU - Pawa, Leily D.
AU - Ambar, Edwin
AU - Riswan, Riswan
AU - Duwit, Feliks
N1 - Publisher Copyright:
© 2026 The Authors.
PY - 2026/4
Y1 - 2026/4
N2 - Background Cardiovascular and cerebrovascular diseases are the top global causes of mortality. Internal medicine professionals are vital in educating the public on prevention, yet they themselves may experience the very risk factors they warn against. Objectives This study aimed to assess cardiometabolic risk factors among Indonesian internal medicine specialists to raise awareness among health care workers. Methods This cross-sectional study was conducted by the Indonesian Society of Internal Medicine (INASIM). Our study recruited 1,568 internal medicine specialists from 39 INASIM branches in Indonesia using clustered random sampling (December 2023-March 2024). Cardiometabolic risk was calculated using atherosclerotic cardiovascular disease (ASCVD) risk scores and SCORE-2 (Systematic Coronary Risk Evaluation-2) Asia Pacific. Results The mean age of 1,064 participants who completed the study was 45 ± 10.4 years. The prevalences of dyslipidemia, obesity, hypertension, and diabetes mellitus were 84.6% (95% CI: 82.4%-86.9%), 61.4% (95% CI: 58.5%-64.3%), 20.3% (95% CI: 17.9%-22.7%), and 10.2% (95% CI: 8.4%-12.1%), respectively. Participants’ 10-year ASCVD risk scores were 6.0% (95% CI: 4.4%-8.1%) high, 18.5% (95% CI: 15.7%-21.7%) intermediate, 9.6% (95% CI: 7.5%-12.1%) borderline, and 66.0% (95% CI: 62.2%-69.6%) low. Their SCORE-2 Asia Pacific risk scores were 1.2% (95% CI: 0.5%-2.5%) very very high, 10.7% (95% CI: 8.3%-13.7%) very high, 46.5% (95% CI: 42.1%-50.9%) high, and 41.6% (95% CI: 37.3%-46.1%) moderate. Conclusions The prevalences of dyslipidemia and obesity were high among internal medicine specialists in Indonesia. The prevalences of highest risk category profile were 6.0% (ASCVD) and 1.2% (SCORE-2).
AB - Background Cardiovascular and cerebrovascular diseases are the top global causes of mortality. Internal medicine professionals are vital in educating the public on prevention, yet they themselves may experience the very risk factors they warn against. Objectives This study aimed to assess cardiometabolic risk factors among Indonesian internal medicine specialists to raise awareness among health care workers. Methods This cross-sectional study was conducted by the Indonesian Society of Internal Medicine (INASIM). Our study recruited 1,568 internal medicine specialists from 39 INASIM branches in Indonesia using clustered random sampling (December 2023-March 2024). Cardiometabolic risk was calculated using atherosclerotic cardiovascular disease (ASCVD) risk scores and SCORE-2 (Systematic Coronary Risk Evaluation-2) Asia Pacific. Results The mean age of 1,064 participants who completed the study was 45 ± 10.4 years. The prevalences of dyslipidemia, obesity, hypertension, and diabetes mellitus were 84.6% (95% CI: 82.4%-86.9%), 61.4% (95% CI: 58.5%-64.3%), 20.3% (95% CI: 17.9%-22.7%), and 10.2% (95% CI: 8.4%-12.1%), respectively. Participants’ 10-year ASCVD risk scores were 6.0% (95% CI: 4.4%-8.1%) high, 18.5% (95% CI: 15.7%-21.7%) intermediate, 9.6% (95% CI: 7.5%-12.1%) borderline, and 66.0% (95% CI: 62.2%-69.6%) low. Their SCORE-2 Asia Pacific risk scores were 1.2% (95% CI: 0.5%-2.5%) very very high, 10.7% (95% CI: 8.3%-13.7%) very high, 46.5% (95% CI: 42.1%-50.9%) high, and 41.6% (95% CI: 37.3%-46.1%) moderate. Conclusions The prevalences of dyslipidemia and obesity were high among internal medicine specialists in Indonesia. The prevalences of highest risk category profile were 6.0% (ASCVD) and 1.2% (SCORE-2).
KW - ASCVD
KW - cardiometabolic syndrome risk
KW - internal medicine specialist SCORE-2 Asia Pacific
UR - https://www.scopus.com/pages/publications/105033670210
U2 - 10.1016/j.jacasi.2025.09.024
DO - 10.1016/j.jacasi.2025.09.024
M3 - Article
AN - SCOPUS:105033670210
SN - 2772-3747
VL - 6
SP - 510
EP - 520
JO - JACC: Asia
JF - JACC: Asia
IS - 4
ER -